A growing body of research suggests that curcumin, the major active constituent of the
dietary spice turmeric, has potential for the prevention and therapy of cancer. Preclinical …

Curcumin (diferuloylmethane) is a polyphenol derived from the plant Curcuma longa,
commonly called turmeric. Extensive research over the last 50 years has indicated this …

Curcumin I (Cur I) and curcumin III (Cur III) are the yellow coloring phenolic compounds
isolated from the spice turmeric. The effect of curcumins on different stages of development …

Curcumin, the main active compound of the curcuma root, shows antioxidant, anti-
inflammatory, and antitumor properties which have been demonstrated in preclinical and …

Inhibition of defined molecular steps of tumorigenesis by natural nontoxic compounds may
be an efficient means to tackle the population cancer burden. Extensive research has …

Curcumin, a well-known dietary pigment derived from Curcuma longa, inhibited growth of
several types of malignant cells both in vivo and in vitro. However, its mechanism of action …

Curcumin, a natural component of the rhizome of curcuma longa has emerged as one of the
most powerful chemopreventive and anticancer agents. Its biological effects range from …

Curcumin, the key bioactive phytochemical present in turmeric (Curcuma longa L.), is the
most studied natural compound in cancer. Preclinical studies (in vitro and in vitro) and …

Chemoprevention is a promising anti-cancer approach with reduced secondary effects in
comparison to classical chemotherapy. Curcumin, one of the most studied chemopreventive …

Despite significant advances in treatment modalities over the last decade, neither the
incidence of the disease nor the mortality due to cancer has altered in the last thirty years …